ConductScience.org, home

Paper34492005

The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis.

Chan XHS and 16 others. PLoS Med, 2021. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis. Papers, record 34492005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34492005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis.
PubMed
Journal
PLoS Med
PubMed
Year
2021
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2024-08-15
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chan XHSXin Hui Shttps://orcid.org/0000-0002-9941-6975
2Haeusler ILIlsa Lhttps://orcid.org/0000-0002-2890-447X
3Win YNYan Naunghttps://orcid.org/0000-0002-9078-5029
4Pike JJames
5Hanboonkunupakarn BBorimashttps://orcid.org/0000-0001-8729-1442
6Hanafiah MMaryam
7Lee SJSue Jhttps://orcid.org/0000-0002-8409-4248
8Djimdé AAbdoulayehttps://orcid.org/0000-0003-0062-2283
9Fanello CICaterina I
10Kiechel JRJean-René
11Lacerda MVMarcus Vghttps://orcid.org/0000-0003-3374-9985
12Ogutu BBernhards
13Onyamboko MAMarie A
14Siqueira AMAndré Mhttps://orcid.org/0000-0003-2208-0294
15Ashley EAElizabeth Ahttps://orcid.org/0000-0002-7620-4822
16Taylor WRWalter Rjhttps://orcid.org/0000-0001-6236-0464
17White NJNicholas Jhttps://orcid.org/0000-0002-1897-1978

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmodiaquineMajor topic
AntimalarialsMajor topic
BradycardiaMajor topic
Heart Conduction SystemMajor topic
Heart RateMajor topic
Long QT SyndromeMajor topic
Adolescent
Adult
Cardiotoxicity
Child
Child, Preschool
Female
Humans
Infant
Male
Middle Aged
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Young Adult

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed
MR/N013468/1Medical Research CouncilUnited KingdomPubMed
107886/Z/15/ZWellcome TrustUnited KingdomPubMed
106698/Z/14/ZWellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121709098Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21709098PubMed
229606364
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
Lancet2018https://conductscience.org/library/papers/29606364PubMed
333278936Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.Lancet2020https://conductscience.org/library/papers/33278936PubMed
43878759The anticholinesterase activity of mefloquine.Clin Exp Pharmacol Physiol1985https://conductscience.org/library/papers/3878759PubMed
511791962Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients.Am J Trop Med Hyg2001https://conductscience.org/library/papers/11791962PubMed
623591829Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study.Drug Saf2013https://conductscience.org/library/papers/23591829PubMed
72138674Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.J R Soc Med1990https://conductscience.org/library/papers/2138674PubMed
828049523Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.Malar J2017https://conductscience.org/library/papers/28049523PubMed
928722611
Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria.
Am J Trop Med Hyg2017https://conductscience.org/library/papers/28722611PubMed
1032134952Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data.PLoS Med2020https://conductscience.org/library/papers/32134952PubMed
1119404632Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers.Eur J Clin Pharmacol2009https://conductscience.org/library/papers/19404632PubMed
1228556586Dihydroartemisinin-piperaquine versus artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana: an open-label, randomised, non-inferiority trial.Trop Med Int Health2017https://conductscience.org/library/papers/28556586PubMed
1318415093Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers.Eur J Clin Pharmacol2008https://conductscience.org/library/papers/18415093PubMed
1414197832QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.Circulation1964https://conductscience.org/library/papers/14197832PubMed
1520368402Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20368402PubMed
1627764102
Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
PLoS One2016https://conductscience.org/library/papers/27764102PubMed
1725515698Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.Malar J2014https://conductscience.org/library/papers/25515698PubMed
1826660066Predicting drug-induced QT prolongation and torsades de pointes.J Physiol2016https://conductscience.org/library/papers/26660066PubMed
1930038039Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/30038039PubMed
207256355Investigation of the anti-acetylcholinesterase activities of the antimalarial agent, amodiaquine, and related compounds.Southeast Asian J Trop Med Public Health1981https://conductscience.org/library/papers/7256355PubMed

See all 51 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41588921Amodiaquine Enhances Anti-Melanoma Efficacy of Attenuated Salmonella via Targeting Glutathione Reductase in Neutrophils.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41588921PubMed
41568626Histamine N-methyltransferase upregulation, cardiac hypertrophy, and heart failure.Eur Heart J2026https://conductscience.org/library/papers/41568626PubMed
37735560Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda.Nat Med2023https://conductscience.org/library/papers/37735560PubMed
36256474Cardiovascular concentration-effect relationships of amodiaquine and its metabolite desethylamodiaquine: Clinical and preclinical studies.Br J Clin Pharmacol2023https://conductscience.org/library/papers/36256474PubMed
35209067Evaluation of Nutritional Substances and Investigation of Antioxidant and Antimicrobial Potentials of Boerhavia diffusa with in Silico Molecular Docking.Molecules2022https://conductscience.org/library/papers/35209067PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ACHE43PubTator's text mininghttps://conductscience.org/library/genes/43

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34492005

GET https://conductscience.org/api/papers/v1/34492005/references?page=2